These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26786825)

  • 1. Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe.
    Castelino RL; Peterson G
    Evid Based Med; 2016 Apr; 21(2):68. PubMed ID: 26786825
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.
    Tuot DS; Lin F; Shlipak MG; Grubbs V; Hsu CY; Yee J; Shahinian V; Saran R; Saydah S; Williams DE; Powe NR;
    Diabetes Care; 2015 Nov; 38(11):2059-67. PubMed ID: 26307607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.
    Shaw JS; Wilmot RL; Kilpatrick ES
    Diabet Med; 2007 Oct; 24(10):1160-3. PubMed ID: 17672860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin: effective and safe in renal disease?
    Herrington WG; Levy JB
    Int Urol Nephrol; 2008; 40(2):411-7. PubMed ID: 18368503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.
    Warren RE; Strachan MW; Wild S; McKnight JA
    Diabet Med; 2007 May; 24(5):494-7. PubMed ID: 17367305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal status among patients using metformin in a primary care setting.
    Kennedy L; Herman WH;
    Diabetes Care; 2005 Apr; 28(4):922-4. PubMed ID: 15793196
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of serum creatinine and kidney function among incident metformin users.
    Schorr M; Hemmelgarn BR; Tonelli M; Soo A; Manns BJ; Bresee LC;
    Can J Diabetes; 2013 Aug; 37(4):226-230. PubMed ID: 24070885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of metformin use in patients with kidney disease: are they warranted?
    Vasisht KP; Chen SC; Peng Y; Bakris GL
    Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media.
    Parra D; Legreid AM; Beckey NP; Reyes S
    Pharmacotherapy; 2004 Aug; 24(8):987-93. PubMed ID: 15338847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.
    Shin JI; Sang Y; Chang AR; Dunning SC; Coresh J; Inker LA; Selvin E; Ballew SH; Grams ME
    J Am Soc Nephrol; 2020 Aug; 31(8):1847-1858. PubMed ID: 32660971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Correlation Between Urinary 8-Iso-Prostaglandin F2α and Hydrogen Peroxide Toward Renal Function in T2DM Patients Consuming Sulfonylurea and Combination of Metformin-Sulfonylurea.
    Sauriasari R; Wulandari F; Nurifahmi R; Sekar AP; Susilo VY
    Curr Diabetes Rev; 2018; 14(2):189-195. PubMed ID: 27981897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of metformin in the setting of mild-to-moderate renal insufficiency.
    Lipska KJ; Bailey CJ; Inzucchi SE
    Diabetes Care; 2011 Jun; 34(6):1431-7. PubMed ID: 21617112
    [No Abstract]   [Full Text] [Related]  

  • 19. Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes.
    Troya MI; Bonet J; Salinas I; Torres F; Bonal J; Sanmartí A; Romero R
    Med Clin (Barc); 2016 Jan; 146(2):55-60. PubMed ID: 26343155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes treatment in patients with chronic kidney disease].
    Süfke S; Steinhoff J; Schütt M
    Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.